Investment, Funding & Disinvestments

The facility, which is expected to begin operations in 2027, will become Align Technology’s first manufacturing site in India and its fourth worldwide.

The appeal followed discussions held during the 79th World Health Assembly (WHA79), where climate-related health risks featured prominently across several agenda items.

The initiative supports Moscow’s broader oncology modernization strategy, which combines investments in diagnostic technology, artificial intelligence, and clinician education to improve patient outcomes.

The ambitious project targets approximately 1.2 million residents, most of whom inhabit rural communities where traditional connectivity has remained inconsistent.

Health authorities estimate that approximately 20,000 babies are born with the condition each year, while nearly 30 percent of the population carries the sickle cell trait.

The acquisitions of Curevo, LimmaTech Biologics, and Vaccine Company mark the drugmaker’s eighth, ninth, and tenth deals of 2026 as it continues to diversify beyond its blockbuster obesity and diabetes franchises.

The proposed acquisition comes at a time when radiopharmaceuticals are attracting unprecedented attention from investors, healthcare providers, and pharmaceutical manufacturers.

Researchers tested the therapy through the MATCH clinical trial, which involved 50 patients with advanced liver cirrhosis.

Edge Growth, in partnership with FNB’s Vumela Fund, backed Mia Healthcare at a pivotal stage of its development, reinforcing investor confidence in its business model and growth trajectory.

The deal gives Olympus access to BioProtect’s commercially available implant system designed to protect healthy tissue during radiation therapy.